H. Lee Moffitt Cancer Center and Research Institute
With
Florida Cancer Innovation Fund
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
Histologically or cytologically confirmed diagnosis of pancreatic exocrine malignancy (e.g.pancreatic ductal adenocarcinoma, acinar cell carcinoma, pancreatic adenosquamous carcinoma, etc.) or clinical features highly suggestive of such malignancy with diagnostic confirmation anticipated during the screening or early study period.
Presentation consistent with resectable, borderline resectable, local, or locally advanced, or metastatic disease
May or may not have had surgery
Treatment plan likely includes systemic therapy for pancreatic cancer
ECOG performance status 0-2
Able to tolerate oral intake and not currently receiving enteral or parenteral nutrition
Able to read and speak English
Able to provide written informed consent
You may not be if
Pregnant or breastfeeding at the time of enrollment
Current use of tube feeding (enteral) or total parenteral nutrition
Presence of ascites or other findings suggestive of decompensated disease
Evidence or history of bowel obstruction or any gastrointestinal condition that may limit food intake
Severe or uncontrolled psychiatric illness (e.g., psychosis, dementia) that would interfere with participation
Presence of other uncontrolled intercurrent illnesses (e.g., infection, heart failure, liver failure) that may interfere with protocol adherence
Clareo Health | A First-in-Human Study of FID-022 in Solid Tumor Patients
